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Summal'y 
Adult mice have two easily recognizable subsets of B cells: the predominant resting population 
of the spleen, called B-2, and those called B-l, which predominate in coelomic cavities and can 
express CDS. Some antibody specificities appear to be unique to the B-1 population. Cells expressing 
antibody specific for phosphatidyl choline (PtC) are the most frequent, comprising 2-10%  of 
peritoneal B cells in normal mice. To understand the basis for the segregation of the anti-PtC 
specificity to this population, we have produced transgenic (Tg) mice expressing the rearranged 
VH12 and VD genes of a PtC-specific B-1 cell lymphoma. We find that V.12-Tg and Va12/VD 
double-Tg mice develop very high numbers of PtC-specific peritoneal and splenic B cells. These 
cells have the characteristics  of B-1 cells; most are CD5 +, and are all IgM  ~, B2201~ and CD23-. 
In the peritoneum these cells are also CD11b +.  In addition, adult mice have many splenic B 
cells (up to one third of Tg § cells) that express the V.12 Tg but do not bind PtC, presumably 
because they express  a V~ gene other than V~4. These cells  appear to be B-2 cells;  they are 
CD23 +, CD11b-,  IgM  1~ B220  hi, and CD5-.  Thus, mice given either the VH12 Tg alone or 
together with  the V~4 Tg develop a large population  of PtC-specific B  cells which belong 
exclusively to the B-1 population. Since B-2 cells can express the V.12 and V~4 gene separately, 
we interpret these data to indicate that the events leading to the segregation of PtC-specific B 
cells to the B-1 population in normal mice are initiated after Ig gene rearrangement and expression. 
These data are discussed with regard to hypotheses of the origin of B-1 cells. We also find that 
VH12-Tg mice have a marked decrease in the generation of Tg-expressing B cells in adult bone 
marrow, but not newborn liver. We speculate that this may be related to positive selection of 
V.12-expressing B cells during differentiation. 
~ 
ult mice contain, at least, two stable,  distinct popula- 
tions of B lymphocytes (for reviews see references 1-3); 
these have been designated B-1  (formerly CD5 + , Ly-1 B) 
and B-2  (formerly conventional) (4).  B-1 cells are the pre- 
dominant population in the peritoneal cavity, and B-2 cells 
are the predominant population in spleen and lymph nodes. 
One of the notable differences between B-1 and B-2 cells are 
their expressed V. repertoires and Ig specificities  (5).  An- 
tigens recognized predominantly or exclusively by the mlgM 
of B-1 cells include phosphatidyl choline (PtC), 1 DNA, Ig 
(rheumatoid factor), and common bacterial carbohydrate an- 
tigens (e.g., phosphorylcholine [6-10]).  Probably the most 
1 Abbreviations used in this paler: 2~4  b, B10.H-2aH-4  b mice; PerC, peritoneal 
cells; PtC, phosphatidyl choline; Tg, transgenic. 
frequent Ig specificity expressed by B cells is that for the ubiq- 
uitous self-membrane phospholipid, PtC (6,  11). In normal 
mice, this specificity is expressed by 2-10%  of peritoneal B 
cells and ",,0.3%  of normal splenic B cells (6) and appears 
to be expressed exclusively by B-1 cells (6, 8,  12,  13). IgM 
specific for PtC is encoded predominantly by either of two 
combinations of VH and VL: VH11 and a V~9 gene, or V.12 
and a VD  gene (13-18).  Each V  gene pair is represented 
about equally in the adult B-1 population of B10.H-2aH-4  b 
(2~4  b) mice (14).  These findings and the restriction of the 
V. CDR3  sequences of anti-PtC B-1 cells argue that these 
cells in the adult are antigen-selected (17,  19). 
The origins of B-1  and B-2 cells are controversial. Two 
views have been offered. The more long-standing view is that 
B-1 and B-2 cells arise from distinct progenitors committed 
to their respective lineages before expression of Ig (20, 21; 
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esis (24, 25), stimulated by the findings ofYing-zi et al. (26), 
proposes that the different types of B cells are the result of 
distinct antigen-induced differentiative pathways. According 
to this hypothesis, commitment to one or the other pathway 
occurs after mIg expression. The signal determining which 
pathway is followed is the result of the first encounter with 
antigen;  interaction with TI-2 antigens and no T.  interac- 
tion  leads  to  the  B-1  phenotype.  The majority  of IgM § 
IgD + B cells, which have not encountered antigen,  are un- 
committed,  and these we term B-0 cells (25).  B-0 cells are 
equivalent to resting B-2 cells as defined by the former hy- 
pothesis  (4). 
To understand the development orB-1 cells and, in partic- 
ular, the basis for the segregation of anti-PtC B cells to the 
B-1 subset, we have produced transgenic (Tg) mice expressing 
a V.12 heavy chain or VK4 light chain derived from the PtC- 
specific lymphoma CH27.  We have examined the ability of 
these mice to produce PtC-specific B-1 and B-2 (B-0) cells. 
We find that  there is an  exclusive segregation  of the PtC 
specificity to the B-1 phenotype.  In addition,  we find that 
adult V.12-Tg mice have a severely limited ability to gener- 
ate B cells in the bone marrow.  These results are discussed 
with  regard to the origin  of B-1  and B-2 (B-0) cells. 
Materials and Methods 
V,  I2.CH27-C,u Construct.  The V.12.CH27-C# construct con- 
tains a V.12-DSP2.9-JH1 segment joined to the 5' end of a frag- 
ment containing the # constant region gene (C~; IgM  ~) (see Fig. 
1). The C#-~M fragment was isolated as a 12.8-kb segment from 
an  EcoRI  digest  of HyHEL10-~-~  (27),  a  kind  gift  of Dr. 
Christopher Goodnow (Howard Hughes Medical  Institute and 
Department of Microbiology and Immunology, Stanford Univer- 
sity, Stanford, CA). The V.12-DSP2-J.1 segment was isolated  as 
a 3.3-kb EcoRI fragment from CH27.LX, a B-1 (CD5 +) cell lym- 
phoma of B10.H-2aH-4bp/Wts origin (2~4b; IgH  b) (28). Genomic 
DNA from CH27.LX was digested to completion with EcoRI and 
size fractionated on a 0.8% agarose gel. The fraction containing 
the 3.3-kb-productive VDJ. rearrangement was  identified  with 
the J.-specific  probe pJ11 (29)  and cloned into Charon27  (30). 
Positive clones were identified by hybridization to a V.12-specific 
probe (16) and plaque purified. 
The  V.12-DSP2-J.1  and  C#  fragments  were cloned  into  a 
vector derived from pSV2-Neo (31). The vector (pSV2-Neo-MPL) 
was modified by removing the SfiI site in pSV2-Neo by Klenow 
fill-in and religation. The vector was  then cut with EcoRI and 
blunt ended by a Klenow fiU-in reaction. A polylinker, assembled 
by annealing two complementary oligonucleotides that had first been 
phosphorylated with  T4  polynucleotide kinase,  was  blunt-end 
cloned into this site. The nucleotide sequence of one oligonucleo- 
tide is: 5'-GGTCGACGCGC~CGCGAATTCATAGGTACCGGC- 
CACGTAGGCCGTCGACC-Y.  The polylinker contains recognition 
sites for the following restriction endonucleases:  5'-SalI-  NotI- 
EcoRI-KpnI-SfiI-SalI-3'.  It was designed to allow multiple cloning 
strategies  and to be able to remove the entire insert by SalI diges- 
tion. The V.12-DSP2-J.1  fragment was cloned into the EcoRI site 
in the polylinker. A clone with the insert in the correct orientation 
was partially digested with EcoR.I and ligated to the C~-containing 
EcoRI fragment. Clones containing the C~ EcoRI fragment in 
the correct orientation and position relative to the V.12-DSP2-J.1 
segment were identified by restriction endonuclease analyses. The 
identity of the VDJ. segment in the clone used for transfection 
and microinjection was confirmed by dideoxy sequence  analysis. 
This fragment initially contained an intact #  switch region up- 
stream of the C# exons. However, deletions in the # switch region 
occurred during replication such  that the size of the EcoRI C/L 
fragment in the DNA used for microinjections ranged from 12.0 
to 9.7 kb. 
The ability of the V.12.CH27-C/~ construct to encode a func- 
tion IgM protein was tested by transfection into an Ig heavy-chain 
loss variant of CH12 (IgM b) (32). The plasmid was linearized  by 
digestion with SfiI and electroporated into cells. Stable transfec- 
tants were selected in the presence of 0.4 mg/ml G418 (Geneticin; 
Sigma  Chemical Co., St. Louis, MO).  Expression  was analyzed 
by immunofluorescence  for mIgM ~  and by ELISA for secreted IgM 
(see below; data not shown). 
V,4.CH27-C~ Construct.  The V~4.CH27-C~ construct contains 
the V~4-J~4-C~ genes expressed by CH27.LX (28). Genomic DNA 
from CH27.LX was digested to completion with BamHI and size 
fractionated on 0.6% agarose gel. The fraction containing the 8.5- 
kb-productive V~-J~ rearrangement was identified with the J~-C~ 
probe  pEC~ (33)  and  cloned  into  the  BamHI  site  of EMBL3 
(Promega Corp., Madison,  WI). Positive clones were identified by 
hybridization  to a J~-specific probe (a 2.9-kb HindIII fragment iso- 
lated from pEC,) and plaque  purified. The V~4-J~4-C~ fragment 
was then cloned into the BamHI site in a modified pSV2-Neo vector 
(this vector has the polylinker described above except that the vector 
SfiI site was retained).  The identity of the VK4-J~4 segment in the 
clone used for transfection and microinjection was confirmed by 
dideoxy sequence  analysis (28). 
The ability of the V~4-J~4-C~ fragment to encode a functional 
K light chain was tested by transfection into P3-X63-Ag8.653,  a 
nonsecreting myeloma line (34). The plasmid was linearized with 
NotI and electroporated into cells. Stable transfectants were selected 
in the presence of 0.4 mg/ml G418.  Transfectants  were selected 
for expression of secreted x light chain (analyzed by ELISA). The 
V~4-JK4-C~ fragment was  shown  to pair with  the V.12.CH27- 
C/x-encoded heavy chain by cotransfecting myeloma cells with both 
constructs. Stable transfectants secreting IgM,~c Ig were identified 
by ELISA. 
Microinjection and Founder Tg Mice.  The V.12.CH27-C#  and 
V~4-J~4-C~ fragments were isolated  from vector DNA by diges- 
tion with SalI and BamHI, respectively,  and purified by agarose 
gel electrophoresis.  The DNA was microinjected separately  into 
(C57BL/6  x  SJL)F2 (IgM  b) fertilized eggs by the National Tram- 
genic Facility of DNX, Inc. (Princeton, N  J). Mouse lines carrying 
either the V.12.CH27-C# or the V~4-J~4-C~ Tg were identified by 
Southern blot analysis of taft DNA by use of the pJll  or pEC~ 
probes, or by PCR with, for V.12, framework 1-(CTTCCTTAC- 
CTGCTCTATTACTGGTTTCC; bp 54-82  of V.12) and J,-spe- 
cific (CTATCCTTACAGAAAAGCTTCTGCAGC;  95  bp  3'  of 
J.1) amplimers and, for V~4, V~4 (5' AGCTCAAGTATAAGTTC- 
CAATTACTTGCAT 3') and J,4 (5' GTTACCCAAACAGAAC- 
CAAAACGTCACA 3') amplimers. 
Mice.  Lines of Tg mice have been maintained by backcrossing 
male  Tg +  mice  with  female  2q b  mice.  Tg +  offspring  were 
identified by PCR analysis or serology. Mice are bred and main- 
tained in our own pathogen-free mouse colony. 
Hybridomas.  Hybridomas from V.12-Tg mice were prepared as 
described previously (14). Briefly, spleen cells were cultured over- 
night in R.PMI  1640 medium containing 50/zg/ml LPS and 20 
#g/ml dextran sulfate. Cells were harvested and fused by use of 
polyethylene glycol with the Ag8.653 myeloma. Supernatant from 
wells containing growing cells was screened for IgM by ELISA. 
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monoclonality. 
Genomic Blot Hybridizations.  To prepare hybridoma DNA, ,~5 
x  107 cells were washed in PBS and resuspended in 0.5 ml diges- 
tion buffer consisting of 100 mM NaC1, 10 mM Tris-C1, pH 8, 
25 mM EDTA, pH 8, 0.5%  SDS, and 0.1 mg/ml proteinase K. 
After an overnight incubation at 50~  the DNA was extracted 
once with phenol, once with phenol/chloroform (1:1), and once 
with chloroform. The DNA was then precipitated  by adding a half 
volume of 7.5 M ammonium acetate and 2 vol ethanol. The precipi- 
tated DNA was spooled out of the ethanol with a glass rod, rinsed 
with 70% ethanol, and resuspended in 100 #1 Tris-EDTA (TE). 
Analysis was by the method of Southern (35). DNA was digested 
with BamHI and electrophoresed through 0.7% agarose gels. The 
DNA was transferred to nitrocellulose and hybridized with the 
J,-specific probe pEC~ (33). The  final wash conditions  were 
30 mM NaC1/3 mM sodium citrate/0.1%  SDS at 68~ 
Antibodies and Liposomes.  mAbs  against the following mole- 
cules were used in these studies: IgM  b (AF6-78), IgM  ~ (DS-1), 
B220 (RA3-6B2), CD5 (53-7.3), and CD8 (53-6.7) were obtained 
from  Pharmingen  (San Diego, CA),  either fluoresceinated, bi- 
otinylated, or conjugated to PE. Anti-CD23 (B3B4) (biotinylated) 
was the kind gift of Dr. Tom Waldschmidt (University of Iowa, 
Iowa City, IA) and anti-CDllb (Mac-l; M1/70) (biotinylated)  was 
generously provided by Dr. Elizabeth Reap (University of North 
Carolina, Chapel Hill, NC). In two-color analyses,  the biotinylated 
reagent was developed with streptavidin-R-PE (Jackson Immuno- 
Research Laboratories, Inc., West Grove, PA). In three-color ex- 
periments, directly fluoresceinated and PE-conjugated antibodies 
were combined with a biotinylated antibody revealed with strep- 
tavidin-RED670 (GIBCO BRL, Gaithersburg,  MD). A monoclonal 
anti-V.12 idiotype (5C5, rat IgG) was produced in one of our labs 
(L. W. Arnold and G. Haughton). This antibody recognizes the 
product of the V.12 gene independently of light- and heavy-chain 
CDR3 (data not shown). The use of fluorochrome-encapsulating 
liposomes to detect membrane-bound PtC-specific Ig has been de- 
scribed previously (6). In these experiments, the liposomes encap- 
sulated either carboxyfluorescein  or sulforhodamine B. 
Immunofluorescence and Flow Cytometry.  To detect membrane 
molecules, single-ceU  suspensions were prepared in HBSS (without 
Ca  2+ , Mg  2§ , and phenol red) containing 0.1% sodium azide and 
0.5% FCS (buffer). Cells were incubated with previously deter- 
mined saturating amounts of antibody in 25-50/xl buffer for 20 
min, after which they were washed three times with buffer and 
incubated with second-step reagents. After washing as before, the 
cells were analyzed with a FACScan  |  (Becton Dickinson, Moun- 
tain View, CA) with acquisition  computer and software  from Cyto- 
mation (Fort Collins, CO), unless otherwise noted. All data repre- 
sent cells falling  within the lymphocyte  gate determined  by forward 
and 90  ~ light scatter; 10,000-50,000 cells were analyzed. 
ELISA.  Detection of V.12 Id, IgM  ~ allotype, x light chain, 
and total IgM were performed by ELISA as previously described 
(6). Assays were quantifed with mAb standards of known IgM 
concentration. Trapping reagents for each analysis  were anti-V.12 
Id, anti-IgM  ~ (DS-1; Pharmingen), goat anti-mouse x, and goat 
anti-mouse IgM (Southern Biotechnology  Associates, Birmingham, 
AL). Assays  were developed  with alkaline  phosphatase-conjugated 
goat anti-mouse IgM (Southern Biotechnology Associates). 
Results 
Tg Mice 
The  expressed  V.  and VK rearrangements  of the  PtC- 
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specific B cell lymphoma CH27 (19) were used to generate 
Tg mice to examine the development  of V.12-expressing  and 
PtC-specific B cells. These genes were cloned into C~ (Igh-a) 
or C~ expression  vectors  (Fig.  1),  and separate heavy- and 
light-chain Tg mice were produced. Four V.12 C~ founder 
lines were established,  and two (7-2 and 6-1) were selected 
for extensive study. Line 7-2 contains 1-2 copies of the Tg, 
and 6-1 contains 15-20  copies. Mice have been backcrossed 
to  2~4  b (IgH  b)  and are  currently in  their  sixth backcross 
generation.  Two V~4 founder lines have been established; 
one (1-2) having 5-10 copies has been characterized and used 
in these experiments.  Mice transgenic for both V.12  and 
VK4 (double Tg) were made by mating 6-1 V,12-Tg females 
with 1-2 V~4-Tg males. 
Characterization of Tg Expression and B Cell Subpopulations in 
V,12-Tg Mice 
Allelic Exclusion.  We have analyzed adult peripheral lym- 
phoid tissues from lines 7-2 and 6-1 for cell surface expres- 
sion of/x chains encoded by the Tg (IgM  ~) and an endoge- 
nous allele (IgMb).  As shown in Figs.  2 and 3,  6-1  mice 
exclude nearly all expression of endogenous C~. Tg C~ is ex- 
pressed by >95% of splenic and peritoneal B cells, and <5% 
of cells express an endogenous C~ (70% of these appear not 
to express the Tg).  In contrast, 7-2 mice appear  to express 
endogenous C~ genes much more frequently. The majority 
(70-90%) of 7-2 peritoneal cells (PerC) express only the Tg, 
and 10-30% (variable between individual mice) express both 
the Tg and an endogenous rearrangement.  On the other hand, 
the majority of 7-2 splenic B cells express an endogenous rear- 
rangement, and about half of these also express low levels 
of Tg C,. Only m10% of splenic B cells appear to express 
only the Tg. 
Allelic  exclusion  in  1-2  V~-Tg mice  was  assessed by 
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Figure  1.  V,12  and V~4 constructs used to produce Tg mice. The rear- 
ranged genes were cloned  from genomic  DNA of CH27, a B-1 cell  lym- 
phoma expressing  IgM specific  for PtC. Restriction  enzymes  are as follows: 
S, SalI; N, NotI; E, EcoRl; B, BamHI;  K, KpnI; Sf, Sill; X, Xbal; H, 
HindlII. 7-2  6-1  DBL  Tgneg 
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Figure  2.  Analysis of peritoneal  cells from V.12-Tg mice. Peritoneal 
cells from three  lines of V.12-Tg mice (7-2,  6-1, and V.12/V~4  double 
[DBL]) were stained with FITC-anti-lgM  ~ or -IgM  b and the biotinylated 
antibody indicated on the left side of the figure. The biotinylated reagents 
were visualized with PE-streptavidin. Fluorescent liposomes contained sul- 
forhodamine.  10,000-20,000  cells were analyzed.  For control and com- 
parison,  analysis of transgene  negative (Tgneg) mice (IgM ~) is included. 
Percentages in the top row denote percent  of total IgM + cells with each 
aUotype; in the other histograms the percentage is that of total IgM * cells. 
Total IgM + cells in the lymphocyte  gate in 7-2, 6-1, DBL, and Tgneg 
mice were 90,  87,  96,  and  715'o, respectively. 
Southern blot analysis  of endogenous J~ rearrangements in 
splenic LPS hybridomas. Hybridomas with hybridizing frag- 
ments in addition to the endogenous germline and Tg frag- 
ments were scored as having failed to undergo Tg-mediated 
allelic exclusion. 12 of 23 (~50%)  hybridomas showed no 
evidence of endogenous V~ gene rearrangements (data not 
shown). Allelic exclusion in (6-1  x  1-2)FI mice that express 
both Tgs appears to be predicted by the phenotype of the 
parents; they express no endogenous heavy chain genes, and 
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Figure  3.  Analysis  of spleen cells from VH12-Tg  mice. Spleen cells from 
Tg § and Tg- mice were stained as described in Fig. 2. Percentages of total 
IgM + cells are as follows: 7-2, 50%; 6-1, 34%; double (DBL), 55%; Tg- 
(Tg"e*), 61%. Percentages denote percent of total IgM § cells  in each box. 
most splenic B cells appear to express the Tg light chain, as 
judged by specificity  for PtC  (see below). 
Analysis of PerG.  The majority of B-1  cells in normal 
young adult mice are found in the peritoneal cavity. Mice 
of all three V,12-Tg lines (7-2,  6-1,  and double) have high 
numbers of PerC B cells expressing the Tg (see Fig.  2).  In 
line 6-1 and the double-Tg mice, nearly all PerC B cells ex- 
press  the Tg. In line 7-2 mice, 70-90%  of PerC B cells ex- 
press the Tg without endogenous heavy chain gene expres- 
sion.  Like PerC B-1  cells of normal mice, Tg + B cells in 
these mice have high levels of IgM and low levels of B220 
and CD23 (36) (compare with Tg-  mouse PerC in Fig.  2). 
Moreover, most of these cells are CD5 + and CDllb +. Thus, 
PerC Tg ~ B cells have the cell surface characteristics of B-1 
cells. About half of the PerC B cells in the double-Tg mouse 
shown in Fig,  2 are CD5-,  but are CD23-  and CDllb + 
(i.e., B-lb cells),  although the number of these cells varies 
among individual mice. Thus, a significant proportion of PerC 
cells in these mice appear to be B-lb (37). Nearly all the Tg + 
B cells from mice of all three V.12-Tg lines are PtC-specific 
as shown by the binding of fluorescent liposomes (Fig. 2). 
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essentially all B cells express the Tg without endogenous C,. 
However, in mice of  both these lines, two clearly distinguish- 
able B cell populations are present. The predominant one is 
mlgM  hi, which expresses CDS,  binds liposomes, is B220  l~ 
CD23-,  and CD11b-  (Figs. 3 and 4).  The other popula- 
tion (larger in 6-1 mice than in double-Tg mice) does not 
bind liposomes, is mlgM  1~ CDS-, CD23 +, and CDllb-. 
Three-color flow cytometric  analysis of 6-1 splenic cells (Fig. 
4) directly demonstrates that the majority of Tg + liposome- 
binding B cells are CD5 +, B2201~ and CD23-, and that the 
majority of Tg + cells that do not bind liposomes are CDS-, 
B220  hi, and CD23 +. Data shown in Fig. 4 also show that 
the liposome-binding cells are larger and more granular than 
those B cells that do not bind liposomes. Therefore, the char- 
acteristics of the predominant liposome-binding  population 
are those orB-1 cells, whereas those of the liposome-negative 
population are those of B-2 (B-0) cells. Thus, all PtC-specific 
cells appear to have the B-1 phenotype. 
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Figure 4.  Three-color immunofluorescence analysis  of spleen cells from 
6-1 V,12-Tg mice. Cells were stained with carboxyfluorescein liposomes, 
PE-anti-IgM', and either  biotinylated  anti-CD5, anti-CD3, anti-B220 
(6B2),  or  anti-CDllb (Mac-l)  (revealed with  streptavidin-RED670). 
IgM' + cells  were selected for analysis by gating and histograms of lipo- 
somes versus CD5, CD23, B220, or CDllb generated. The light scatter 
histograms were generated by gating on the liposome-positive or -negative 
populations. The percentages refer to the percent of cells in the box com- 
pared with the total liposome-positive or -negative cells as appropriate. 
The numbers in the single-parameter histograms refer to the mean channel 
number of the peak (on a 512-channel linear distribution). 35,000 cells 
were analyzed. 
The majority (80-90%) of splenic B cells in 7-2 mice have 
mostly endogenous heavy chains (Fig. 3).  The number of 
CD5 § B cells is slightly higher than in normal mice (~l.5- 
fold), and the number of cells specific for PtC (binding lipo- 
somes) are increased ~15-40-fold above normal (Fig. 3). All 
of the cells specific for PtC express the Tg. However, since 
the percentage of Tg + cells that bind liposomes and the per- 
centage of Tg + cells that are CD5 + and B2201~ are similar 
(11 vs.  15 and 21%, respectively), it is likely that the PtC- 
specific cells have the cell surface characteristics of B-1 cells 
(Fig. 3). Three-color analysis confirms that Tg + tiposome- 
binding B cells are CD5 +, CD23-,  and B220  [~  and Tg + 
liposome-negative cells are CDS-, CD23 +, and B220  ~ (data 
not shown). 
Expression of V,12-Tg Early in Ontogeny.  Liver and spleen 
cells of newborn V,12-Tg mice were examined to determine 
the expression of the Tg and B cell development early in on- 
togeny (Figs. 5 and 6). Newborn livers of both 7-2 and 6-1 
mice contain normal numbers of IgM + B cells. In liver and 
spleen of 7-2 mice, B cells expressing the Tg predominate, 
the reciprocal of that seen in the adult spleen (Fig. 3) and 
bone marrow (see  below). In newborn 6-1 mice, nearly all 
Ig + B cells express the Tg, as seen in the adult. However, 
the IgM § B cells present in newborn Tg mice (both 7-2 and 
6-1) are not predominantly CD5 + (<5%) (Fig. 6; data not 
shown for 7-2 mice). In newborn 6-1 mice, 3-5% oflgM + 
cells bind liposome (Fig. 6). In 6-1 mice, liposome-binding 
IgM + cells increase rapidly, so that by day 3, they represent 
15-20%  of IgM + cells and, by day 6 >80% of IgM + cells 
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Figure 5.  Analysis of B220 +  , IgM + cells in newborn liver of 7-2 and 
6-1 V.12-Tg mice and spleen of 7-2 mice. Cells were stained with the in- 
dicated combinations of anti-B220 (6B2), anti-IgM,, and IgM  b. Cells were 
analyzed on a Coulter EPICS 751 with three decade log amplifiers. The 
percentages in the liver panel illustrate percent of total B220 + cells. In 
the spleen panel, percentages are percent of total Ig * cells. 
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Figure  6.  Analysis of spleen cells from newborn, 1-d-old, and 6-d-old 
V.12-Tg mice. Spleen cells  from young mice were analyzed for expres- 
sion of mIgMh mlgM  b, CD5,  and liposome binding. All analyses  used 
three-color immunofluorescence: carboxyfluorescein-liposome  versus PE- 
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Figure  7.  Analysis  of  bone  marrow  cells  in  V.12-Tg  mice.  Bone 
marrow cells from 7-2 or 6-1 Tg*  and Tg-  mice were analyzed for ex- 
pression of mlgM=, mlgM  b, CD5, and liposome binding. Percentages in 
top row of histograms denote percent of total IgM + cells;  those in the 
lower rows denote percent of total Tg § cells, or in the case of Tg- mice, 
the percent of total lgM + cells. 
in the spleen (Fig. 6 and Table 1). Thus, over the first 120 h 
of postnatal life, the proportion of PtC-specific B cells in- 
creases 20-fold, i.e., doubles about every 24-30 h. At day 6 
of life, the spleen weight, total spleen cells, total IgM § cells, 
and total 8220 § , IgM- cells are essentially no different be- 
anti-IgM~ or -IgM  b versus biotinylated anti-CD5/streptavidin -RED670. 
In B, IgM + cells were gated into liposome-positive or -negative catagories 
and CD5 expression determined for each subset. All percentages refer to 
percent IgM + cells. 
Table  1.  Analysis of Sflenic B  Cells in 6-d-old Vn12-Tg §  Mice 
Number 
of mice  Spleen  Total 
Mice  tested  weight  recovered cells 
IgM+  cells  Liposome-positive cells  B220+,  lgM-  cells 
Percent  Total  Percent  Total  Percent  Total 
mg  x  107 
Tg + 
Experiment  1  2  25.65  +_  3.35*  5.99  +-  0.53 
Experiment 2  5  ND  ND 
Tg- 
Experiment  1  4  29.08  _+  4.03  5.36  +  0.87 
Experiment 2  2  ND  ND 
x  I06 
4.60  +_  0.60  2.73  _+  0.11 
4.28  +  0.45 
3.60  +  0.36  1.93  _+  0.29 
4.95  +__  0.75 
x  106 
4.05  -+  1.05  2.43  -- 0.42 
3.42  _+  0.45 
<0.01  NA 
<0.01 
x  106 
1.70  _+  0.10  1.02  _+  0.15 
4.20  _+  0.77 
1.88  _+  0.25  1.01  _+  0.25 
5.75  _+  0.75 
* Standard deviation. 
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%  of Total Cells  in Lymphocyte Gate 
Total  Total  Total  B2201~  B220 ~~  B2201~  B220 hi,  B220 hi,  PtC 
Mice  IgM*  IgM  ~  IgM  b  B220 +  IgM-  IgM  ~  *  IgM  b  +  IgM  ;*  IgM  b+  specific 
n 
7-2 Tg  4  12.5  3.8  8.6  55.3  40.8  2.3  5.1  2.4  5.8  1.4 
(11.5-13.3)  (49.5-60.2)  (32.3-49)  (1.5-3.0)  (4.0-7.5)  (2.0-2.7)  (4.0-7.5)  (0.8-1.6) 
[22.4]  [6.9]  [15.6]  [74]  [4.2]  [9.6]  [4.3]  [10.5]  [2.5] 
6-1  Tg  4  6.1  5.9  0.2  30  27  3.8  <0.1  1.9  <0.1  2.8 
(5.3-7.2)  (24-38)  (18-37)  (3.1-5.0)  (1.4-2.2)  (1.6-5.0) 
[20.3]  [19.7]  [0.6]  [90]  [12.7]  [6.31  [9.3] 
Tg-  6  26.4  26.4  55.1  30.5  -  10.6  -  17.5  0.4 
(20-34)  (50.0-60.5)  (25-36)  (7.5-13.0)  (9.0-28.5)  (0.2-1.0) 
[47.9]  [47.9]  [55]  [19.2]  [31.8]  [0.7] 
The bone marrow B cell subpopulation distribution from several mice was determined as described in Figs. 6 and 7 and summarized here. The Tg- 
control mice include Tg- mice of the 7-2 line (two mice), 6-1 line (two mice), and 2q  b (two mice). No differences were observed among these 
mice. For 7-2 mice, percent of cells in columns denoting IgM  ~+ cells contain only those that are IgM  ~+ , IgM  b- . Cells in the IgM  b columns are 
IgM  b+ or IgM  ~+ , IgM  b+ . Also, in 7-2 mice, the sum of the B220  +  , IgM + columns exceeds the total IgM* cells because of the inability to com- 
pletely resolve IgM + cells from IgM- cells. Numbers in parentheses are ranges; those in brackets are percentage of B220  + cells. All PtC-specific 
B cells are lgM  ~§ , IgM  b- . 
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Figure 8.  Analysis of subpopulations of B cells in the bone marrow 
of V,12-Tg mice. Bone marrow cells were stained with FITC-anti-IgM  ~ 
or -IgM  b and biotinylated anti-B220 (6B2) (revealed with PE-streptavidin). 
A lymphocyte  gate was established based on forward and 90  ~ light scatter 
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tween  Tg §  mice and  Tg-  littermates.  The increase in the 
frequency of CD5 + B cells directly parallels the increase in 
liposome-binding B cells.  As shown in Fig. 6 B, >90%  of 
liposome-binding IgM* cells  are CD5 §  whereas <10% of 
IgM §  PtC-negative  cells  express  CD5. 
Expression of V,12-Tg  in Adult Bone Marrow.  To examine 
the early stages of B cell differentiation in adult mice, bone 
marrow cells from 2-4-mo-old V,12-Tg mice were analyzed 
for expression of mlgM allotypes and B cell markers.  The 
data are shown for representative individual mice in Figs.  7 
and 8 and summarized in Table 2. 6-1 mice have about two- 
fold fewer total B220 + cells  and  about  fourfold fewer Ig + 
bone marrow B cells than Tg- controls. This is particularly 
evident in the B220  hi, IgM + population, where the decrease 
from normal is ninefold, but is also apparent  (about three- 
fold) in the less mature B2201~  IgM + population (Fig. 8 and 
Table 2). 
Line 7-2 mice have normal numbers of total bone marrow 
B220 + cells, but there are about twofold fewer IgM + B cells 
than in Tg- controls.  Surprisingly, in sharp contrast to the 
as shown. Cells within the gate were analyzed  for B cell subpopulations. 
The distribution of total B220  § cells (d) was divided into three regions 
(as diagrammed at the bottom of the figure): a, B220  +  , IgM- (pro- and 
pre-B cells); (b), B220  hi, IgM + (mature B cells); c, B2201~ lgM + (im- 
mature B cells). Percentages denote percent of total cells in lymphocyte 
gate. Note that in 7-2 mice the number of B220  + cells expressing IgM, 
includes those expressing IgM  *  only and those expressing both heavy  chain 
allotypes. The same is true of those expressing IgML n born  where80%~  IM Bcells Pressth  the  i  1 
majority (70%) of bone marrow IgM + B cells are producing  lOOO 
only an endogenous heavy chain. 
Serum  Ig  in  V,  d2-Tg  Mice.  In  normal  mice,  a  large 
proportion of serum IgM is derived from cells of the B-1 
population (22, 38).  We have analyzed sera from Tg mice  o  100 - 
for  expression  of V.12  idiotype  and  PtC  specificity.  As  ~. 
shown in Fig. 9, V.12-Tg mice have high levels of V.12 idi-  o 
otype in  their serum.  Line 7-2  mice have '~50-fold more  ~- 
V.12  Id  than  Tg-  mice;  6-1  and  double-Tg  mice  have  | 
100-200-fold more. All mice have about the same levels of  ~  lO - 
total serum IgM (800-1,100 #g/ml; data not shown). V.12-  g 
Tg mice also have high levels of serum IgM specific for PtC  g 
@ 
(anti-BrMRBC), as detected by their ability to bind BrMRBC  ,, 
(Fig.  10). Thus, the PtC-specific B-1 cells in these mice are 
secreting substantial amounts of IgM. 
Discussion 
To examine the selection of PtC-specific B cells and the 
basis  for their segregation to the B-1 population,  we have 
produced Tg mice expressing either the V~12/~ heavy chain 
or the V~4 light chain used to encode anti-PtC antibodies. 
We find that V.12-Tg mice have large numbers of B-1 cells 
in spleen and PerC, almost all of which are specific for PtC. 
In 6-1 and double-Tg mice, these cells are the predominant 
splenic B cell population. These mice do not have PtC-specific 
B-2 (B-0) cells, although they do have substantial numbers 
(up to 30%) of splenic B-2 (B-0) ceils that express the V.12 
Tg. These cells do not bind PtC, presumably because they 
express a light chain V  gene other than V~4. Thus,  PtC- 
specific B cells  segregate to the B-1  population. 
There are several possible explanations for the segregation 
of PtC-specific B cells to the B-1 population in normal mice. 
One, cells committed to the B-1 lineage can rearrange the 
V.12  gene  (and/or  the  V~4  gene),  but  B-2  lineage cells 
cannot. Two, B-1 lineage cells can rearrange and express the 
V.12  gene (and the V~4 gene), but  B-2  lineage cells,  al- 
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Figure  9.  Sera  of Tg mice con- 
tain large amounts of V.12 Id + 
IgM.  Serum  from young  adult 
mice were analyzed by ELISA for 
V.12 Id + IgM. For V.12 Id anal- 
),sis,  a rat anti-V.12  Id (specific 
for the V.12  heavy chain  only) 
was  used  for trapping,  and  the 
binding  of serum  IgM was  re- 
vealed  with  goat  anti-mouse 
IgM-alkaline  phosphatase.  All 
mice had equivalent  amounts of 
total  serum  IgM  (800-1,100 
/zg/ml; data not shown).  (DBL 
Tg +) Mice that have both V.12 
and V~4 Tgs; (DBL Tg-) litter- 
mates ofDBL Tg + mice that do 
not  have either  Tg;  and  (DBL 
VH12  +)  Littermates  that  have 
only the V.12 Tg. 
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Figure  10.  Sera of Tg mice contain large amounts oflgM, which binds 
to BrMRBC. Dilutions of sera (heat  treated  to inactivate complement) 
from young adult Tg mice were incubated with BrMRBC. After washing, 
the binding of IgM was revealed with FITC-goat anti-mouse IgM. Calls 
(in triplicate) were analyzed with a PACScan  |  and mean channel fluores- 
cence determined  for each sample. The level of IgM anti-BrMRBC is ap- 
proximately  proportional to the amount of V.12 Id in the serum  (see 
Fig.  8). 
though they can rearrange V.12 (and VA), cannot express 
it. Three, V.12 may be rearranged and expressed by cells of 
either lineage, but PtC-specific B-2 cells are either unselected, 
deleted, or anergized, whereas B-1 cells are selected and clonally 
expanded. Four, PtC-specific B cells are induced to become 
B-1 cells because of the nature of their interaction with an- 
tigen. The first three possibilities  are consistent with the lin- 
eage hypothesis, whereas the final possibility is consistent with 
the induced differentiation hypothesis.  The V.12-Tg mice 
allow us to exclude some of these possibilities. 
A  mechanism for a process of directed Ig V. gene rear- 
rangement that differs between pre-B cells of the two lineages 
is unlikely since this would have to include multiple genes, 
and there are V genes known to be used by B cells of both 
phenotypes (e.g., Vx and several genes of the J558 V186.2 
and V3 subfamilies) (10, 39, 40). However, there is at least 
one report that B-1 and B-2 lineage cells may use different 
sets of V. genes (41), although selective processes cannot be 
excluded as an explanation for these data. The data from the 
V.12-Tg mice demonstrate that this prediction is not neces- 
sary. We have provided the appropriately rearranged V.12 
gene, with its normally associated  regulatory elements, to 
B cells of all lineages, yet both V.12-expressing B-1 and B-2 
(B-0) cells are produced, and PtC-specific B cells appear to 
belong exclusively to  the B-1  subset.  Data from the VA 
mice demonstrate that about half of splenic B cells express 
this Tg, whereas B-1 cells constitute only 5% of splenic B 
cells. Therefore, this VA gene is expressed by B-2 cells, and 
yet PtC-specific B-2 cells are not detectable. 
The second prediction, that only B-1 lineage cells can ex- 
press  the V.12  gene,  requires  that  B-1  lineage cells  have 
DNA binding proteins that recognize regulatory elements 
of a subset of V. and/or V~ genes (e.g., V.12 and VA). The data from the V.12-Tg mice (most easily demonstrated  in 
the 6-1  line mice)  prove that,  at least,  the V.12  and V~4 
genes are not such genes,  since they are expressed by both 
B-1 and B-2 (B-0) cells. Therefore, such a proposed mecha- 
nism  for shaping  the B-1 repertoire is unnecessary. 
Antigen-driven selective mechanisms, therefore,  remain the 
most likely basis for the restricted  and exclusive  repertoire 
of B-1 cells. The high frequency of PtC-specific B cells must 
be due largely to antigen-driven clonal expansion.  Analysis 
of PtC-specific B cells in normal mice clearly establishes that 
B cells with this specificity are antigen  driven (17,  19). V, 
use by B cells of 6-1 Tg mice will be diverse and,  thus,  the 
large number of cells  specific for PtC in adult peritoneum 
and spleen must be due in part to antigen-driven clonal ex- 
pansion of this subset of V.12-expressing B cells. Indeed, se- 
lection is so powerful that V.12-only-Tg mice are not sub- 
stantially  different from double-Tg mice in which both V.12 
and VK4 are provided. Analysis of splenic B cells of young 
6-1 mice indicates that selection proceeds rapidly after birth. 
PtC-specific B cells of 6-1 neonates constitute <5% of IgM + 
cells, even though the total number of B cells appears normal. 
Thus,  VK use must be diverse at this stage and the expan- 
sion of PtC-specific B cells not significantly advanced. PtC- 
specific B cells are 15-20% of IgM + cells on day 3, and this 
frequency increases  to ,,o80% of IgM § cells on day 6. This 
rapid increase in the proportion of PtC-specific B cells could 
be due to clonal selection and expansion of PtC-specific B 
cells, or to just the accumulation of PtC-specific B cells from 
a  population  of B  ceils  expressing  receptors  with  diverse 
specificities.  The latter explanation would require the elimi- 
nation of the vast majority of cells expressing a receptor that 
is not PtC specific and, thus, the spleens of Tg + mice should 
contain low numbers of IgM + B cells compared with Tg- 
mice. As shown in Table  1, they contain the same number. 
The PtC specificity requires the pairing of a particular V~4 
with  the  V,12  expressed  in  the  Tg  mice  and,  assuming 
random VK4 use, this would mean that only ,,ol cell in 200 
would express  a receptor specific for PtC.  Thus,  for V.12- 
Tg mice to acquire 2.43  x  106 PtC-specific B cells by day 
6 (Table 1) without division of the PtC-specific B cells would 
require the production  of 5  x  10  s B cells (2.43  x  106  x 
200), or a production of 108 cells per day. This would mean 
that the mouse would need to produce ~30-40 times more 
IgM + cells  each day than  are contained in the  spleen of a 
6-d-old mouse (normal or Tg+). Thus, it seems inescapable 
that PtC-specific B cells increase as a result of clonal selection 
and proliferation.  It is also apparent,  however, that the number 
of total splenic B cells that  are not. PtC specific in 6-d-old 
Tg + mice is only -o17% of the total number of such cells 
in the Tg-  mice. Thus, it is possible that some PtC-negative 
cells are eliminated, although these data cannot establish this. 
Selection beginning on or about birth is consistent with our 
previous analysis of V.12 rearrangements indicating consid- 
erable  restriction  of V.  CDR3  sequences in  the  neonate 
(42).  Selection of B cells in V.12-Tg  mice is substantially 
different from that  studied in Tg mice expressing antibody 
specific for other self-antigens where the cells are deleted or 
anergized (for reviews see references 43 and 44), suggesting 
that  anti-PtC  has  an important  normal  function in mice. 
However, these data do not formally establish whether these 
selective processes operate before or after lineage commitment. 
Under the concept of the lineage hypothesis, PtC-specific B-1 
cells could be antigen selected and undergo clonal expansion, 
whereas PtC-specific B-2 cells could be unable to undergo 
clonal expansion or be functionally eliminated by clonal de- 
letion or anergy. In the absence of donal expansion,  the re- 
strictions  in  V-(D)-J  rearrangement  and  VK  association 
would limit the frequency of these cells in the repertoire to 
an undetectable level in normal mice. For the same reasons, 
PtC-specific B-2 cells that are tolerized by anergy would be 
undetectable.  However, unexpanded  or anergized  B-2 cells 
in V.12/VK4 double-Tg mice would be at a detectable fre- 
quency (~50%  of B cells) since both the rearranged V. and 
V~ genes are provided. That we do not detect PtC-specific 
B-2 cells in these mice indicates that neither of these mecha- 
nisms is responsible for the absence of B-2 cells with  this 
specificity.  Thus, by the lineage hypothesis, the only selec- 
tive mechanism to exclude the PtC specificity from the B-2 
lineage appears to be clonal deletion, either because of a failure 
to be positively selected in the bone marrow or to negative 
selection.  These data are also consistent with  the antigen- 
induced differentiation hypothesis (24, 25), which states that 
newly generated PtC-specific B cells would be selected into 
the B-1 population.  Thus,  since PtC is a ubiquitous  self- 
antigen, all B cells with anti-PtC receptors would encounter 
antigen and be induced to become B-1 cells, and there would 
be no B-2 (B-0) cells with this specificity. This model is more 
conservative in that it requires only an additional consequence 
of mlg receptor signaling.  In either case, we conclude that 
the events leading to the segregation of the PtC specificity 
to B-1 cells are initiated after Ig gene rearrangement  and ex- 
pression. 
The  most  surprising  observation  from  the  analysis  of 
V.12-Tg  mice is  the decreased numbers  of Ig + B  cells  in 
adult bone marrow, despite the apparent normal development 
of Ig § cells very early in ontogeny. This decrease is greater 
than  is apparent  from just the comparison  of the number 
of Ig + cells (Table  1).  Many of the Tg + B cells in 7-2 and 
6-1 mice are CD5 § and bind liposomes (37 and 47% of Tg + 
cells, respectively [Table 1]). These cells are probably clonally 
selected mature  B-1  cells  that  have  migrated  to  the bone 
marrow, since newly generated B cells specific for PtC should 
be infrequent because of restriction in light chain association 
for this  specificity.  Excluding  the PtC-specific B  cells,  the 
reduction in  the number  of newly generated  B cells  from 
normal is 10- and 8.5-fold in 7-2 and 6-1 mice, respectively. 
This reduction in B cell development appears to affect Tg- 
expressing B cells preferentially. 7-2 mice produce B cells ex- 
pressing  the Tg and B cells expressing  an endogenous V. 
gene (Fig. 6). In newborn 7-2 mice, 80-90%  of B cells are 
Tg + . Thus,  the Tg in these mice appears to exclude endog- 
enous rearrangement well. Since the mechanism of allelic ex- 
dusion should not be different in the adult, the fact that the 
number  of Tg + B cells in adult bone marrow  is less  than 
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the  differentiation  of Tg §  B  cells  in  the bone marrow  is 
selectively affected. B cells expressing endogenous IgM do 
not  compensate  entirely  for  the  reduction  in  Tg §  B  cell 
differentiation, probably because allelic  exclusion by the Tg 
results in relatively few cells  expressing endogenous IgM. 
We speculate that the impairment of B cell differentiation 
in these Tg mice may be related to positive selection of de- 
veloping V,12-expressing B cells. We (25, 42, 45) and others 
(40, 46-48) have proposed that developing B cells,  like de- 
veloping T  ceils  (for reviews see references 49 and 50), re- 
quire rescue from an inevitable progression to apoptosis by 
ligand interaction (positive selection). We have recently demon- 
strated that positive selection of V.12-expressing B cells in 
normal neonatal and adult mice is dependent on the sequence 
of V. CDR3 (42 and Ye, J., L. W. Arnold,  S. K. McCray, 
and S. H. Clarke, manuscript in preparation). This selection 
may occur at the pre-B cell stage and therefore be indepen- 
dent of the light-chain,  or it may occur at the immature B 
cell stage after light chain expression. We have preliminary 
evidence for the former from sorted IgM-  B lineage cells 
of adult bone marrow (Ye, J., and S. H. Clarke, unpublished 
observation). There may also be a requirement  for positive 
selection after light-chain expression, and this could explain 
the loss of a significant  fraction of B cells in the bone marrow 
of V,12-Tg mice if only some V.12/V~ combinations can 
be rescued. An alternative, but not necessarily mutually ex- 
clusive, explanation is that the very high levels of circulating 
PtC-specific IgM in Tg mice interfere with positive selection 
of pre-B or B cells by competing with their cell surface Ig 
receptors for ligand. This idea would also predict the obser- 
vation that B cell development in neonatal mice would not 
be disrupted since there would be probably at most only low 
levels of circulating  anti-PtC  antibody because of the scar- 
city of cells  with  this  specificity. 
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